This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Reinforcing its commitment to global manufacturing excellence, Indian Pharmaceutical Alliance convened the 9 th Advanced Good Manufacturing Practices (GMP) Workshop. The two-day workshop held virtually featured over 25 distinguished industry leaders, subject matter experts, and global regulators, including USFDA and CDSCO.
At the Indian Pharmaceutical Alliance’s (IPA) virtual 9th Advanced Good Manufacturing Practices (GMP) Workshop Dr Rajeev Raghuvanshi, Drugs Controller General of India, CDSCO, Government of India commented, “At the heart of the pharmaceutical industry lies one unwavering principle: Quality.
FDA representatives emphasized the agency’s commitment to working with industry to mitigate potential regulatory hurdles to PCM adoption during USP’s workshop on “ Identifying and Addressing Barriers to Continuous Manufacturing Adoption ” July 18-19 in Rockville, Maryland. It is not intended as a comprehensive summary or report.
Through its standards, scientific expertise, capability building solutions, unique insights, and work with organizations like Duke-Margolis, USP is working to enable a more resilient medicine supply chain so that people can get their medicines when they need them.
The workshop, led by Educator Shailesh KAPADIA, CCPE® , prompted insightful discussions on career-related aspects within the field. He highlighted potential opportunities due to the low cost of skilled labor, expanding market size, and increasing global demand for generic drugs.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content